Enanta Pharmaceuticals: Fiscal 3Q Earnings Snapshot

August 7, 2018

WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Tuesday reported fiscal third-quarter net income of $20.3 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Watertown, Massachusetts-based company said it had profit of 97 cents.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 96 cents per share.

The biotechnology company posted revenue of $57.3 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $56.6 million.

Enanta Pharmaceuticals shares have risen 56 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $91.76, more than doubling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA

Update hourly